Overcoming Persistent Barriers to Effective Management of Atopic Dermatitis

Sunday, 11/18 – 9:30am – 10:50am


Atopic dermatitis (AD) is a chronic inflammatory disease affecting 20% of children worldwide. People with AD suffer from dry, sensitive skin with a characteristic intense itch. For some, especially those with moderate-to-severe atopic dermatitis, the itch may be so intense that the patient scratches until the skin bleeds, leading to even more inflammation and itching and increasing the potential for infection.  AD increases healthcare use and costs. As many as 25% of outpatient pediatric primary care office visits may be because of skin complaints, and AD is responsible for a substantial number of those.

Effective clinical management of AD depends on an accurate diagnosis. However, recent data suggest that insufficient time is allotted to diagnose, and >50% of patients meeting the criteria for AD are misdiagnosed. While accurate diagnosis of AD can be established with an adequate history and physical examination, it often presents with characteristics mimicking other conditions, leading to frequent misdiagnosis.

Learning Objectives

  • Apply primary care-focused and patient-centric guidelines to the diagnosis, management, and treatment of atopic dermatitis
  • Identify and address patient and provide barriers to adherence and effective management and treatment of atopic dermatitis, including effective communication, TCS phobia, and proper use of emolllient agents
  • Review data on newer agents approved for AD and potential impact on disease treatment and patient adherence
  • Improve the quality of patient care related for AD

Target Audience

This activity is targeted to any primary care clinician who treats patients with atopic dermatitis.

Accreditation Information

AMA PRA Category 1 Credit™: The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of North Texas Health Science Center designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

AAFP: Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.


Provided by UNT Health Science Center


This CME presentation is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Dallas Fort Worth 2018

Program Faculty

Jack B. Cohen, DO
Clinical Professor
Department of Dermatology
UT Southwestern Medical Center
Dallas, TX